Literature DB >> 30221050

The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma.

Katerina Kachler1, Corinna Holzinger1, Denis I Trufa2, Horia Sirbu2, Susetta Finotto1.   

Abstract

Despite the opposite roles of Tbet and Foxp3 in the immune system as well as in tumour biology, recent studies have demonstrated the presence of of CD4+ T cells, expressing both, Tbet and Foxp3. Although Tbet+Foxp3+ T cells are currently a subject of intense research, less is known about their biological function especially in cancer. Here we found a considerable accumulation of Tbet+Foxp3+CD4+ T cells, mediated by the immunosuppressive cytokine TGFβ in the lungs of tumour bearing mice. This is in line with previous studies, demonstrating the important role of TGFβ for the immunopathogenesis of cancer. By gathering results both in murine model and in human disease, we demonstrate that, the conversion of IFNγ producing anti-tumoral T-bet+Th1 CD4+ T cells into immunosuppressive Tbet and Foxp3-PD1 co-expressing regulatory cells could represent an additional important mechanism of TGFβ-mediated blockade of anti-tumour immunity.

Entities:  

Keywords:  Foxp3; Immunotherapy; NSCLC; PD1; Tbet

Year:  2018        PMID: 30221050      PMCID: PMC6136856          DOI: 10.1080/2162402X.2018.1456612

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  49 in total

Review 1.  Plasticity of CD4+ T cell lineage differentiation.

Authors:  Liang Zhou; Mark M W Chong; Dan R Littman
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

2.  Lung cancer screening with low dose computed tomography: where do we stand today?

Authors:  R J van Klaveren
Journal:  Eur J Cancer       Date:  2009-09       Impact factor: 9.162

Review 3.  T-bet in disease.

Authors:  Vanja Lazarevic; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

4.  The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

Authors:  Aysefa Doganci; Tatjana Eigenbrod; Norbert Krug; George T De Sanctis; Michael Hausding; Veit J Erpenbeck; El-Bdaoui Haddad; Hans A Lehr; Edgar Schmitt; Tobias Bopp; Karl-J Kallen; Udo Herz; Steffen Schmitt; Cornelia Luft; Olaf Hecht; Jens M Hohlfeld; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Stefan Rose-John; Harald Renz; Markus F Neurath; Peter R Galle; Susetta Finotto
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.

Authors:  Dori A Thomas; Joan Massagué
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.

Authors:  Fuping Zhang; Guangxun Meng; Warren Strober
Journal:  Nat Immunol       Date:  2008-10-12       Impact factor: 25.606

8.  Therapeutical measures to control airway tolerance in asthma and lung cancer.

Authors:  Katerina Andreev; Anna Graser; Anja Maier; Stephanie Mousset; Susetta Finotto
Journal:  Front Immunol       Date:  2012-07-26       Impact factor: 7.561

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.

Authors:  Ljubov Balabko; Katerina Andreev; Nadine Burmann; Melanie Schubert; Martina Mathews; Denis I Trufa; Sarah Reppert; Tilmann Rau; Martin Schicht; Horia Sirbu; Arndt Hartmann; Susetta Finotto
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

View more
  12 in total

1.  Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC.

Authors:  Roberto Martínez; Gustavo Tapia; Silvia De Muga; Alba Hernández; Maria González Cao; Cristina Teixidó; Victor Urrea; Elisabet García; Sònia Pedreño-López; Luis Ibarz; Julià Blanco; Bonaventura Clotet; Cecilia Cabrera
Journal:  Oncoimmunology       Date:  2019-04-13       Impact factor: 8.110

Review 2.  Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.

Authors:  Ee Lyn Lim; Klaus Okkenhaug
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

Review 3.  Treg programming and therapeutic reprogramming in cancer.

Authors:  Mariela A Moreno Ayala; Zehui Li; Michel DuPage
Journal:  Immunology       Date:  2019-04-29       Impact factor: 7.397

Review 4.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

5.  IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer.

Authors:  Lisanne Heim; Zuqin Yang; Patrick Tausche; Katja Hohenberger; Mircea T Chiriac; Julia Koelle; Carol-Immanuel Geppert; Katerina Kachler; Sarah Miksch; Anna Graser; Juliane Friedrich; Rakshin Kharwadkar; Ralf J Rieker; Denis I Trufa; Horia Sirbu; Markus F Neurath; Mark H Kaplan; Susetta Finotto
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

6.  Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer.

Authors:  Lisanne Heim; Katerina Kachler; Raphaela Siegmund; Denis I Trufa; Susanne Mittler; Carol-Immanuel Geppert; Juliane Friedrich; Ralf J Rieker; Horia Sirbu; Susetta Finotto
Journal:  Br J Cancer       Date:  2019-04-08       Impact factor: 7.640

7.  Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.

Authors:  Xingying Zhang; Xin Wen; Ning Feng; Aoxing Chen; Senbang Yao; Xin Ding; Longzhen Zhang
Journal:  Med Sci Monit       Date:  2020-06-20

Review 8.  Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.

Authors:  Chunxiao Li; Ping Jiang; Shuhua Wei; Xiaofei Xu; Junjie Wang
Journal:  Mol Cancer       Date:  2020-07-17       Impact factor: 27.401

9.  Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma.

Authors:  Jaime L Chao; Michael Korzinkin; Alex Zhavoronkov; Ivan V Ozerov; Matthew T Walker; Kathleen Higgins; Mark W Lingen; Evgeny Izumchenko; Peter A Savage
Journal:  Cell Rep Med       Date:  2021-09-14

10.  7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection.

Authors:  María Belén Vecchione; Natalia Laufer; Omar Sued; Marcelo Corti; Horacio Salomon; Maria Florencia Quiroga
Journal:  J Biomed Sci       Date:  2020-01-06       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.